THE DEAL, AT A GLANCE
From the announcementOpenEvidence
01What it doesOpenEvidence is a Digital Health company focused on Build Medical Superintelligence for Doctors.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Thrive Capital, DST GlobalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedOpenEvidence raised $250M Series D, announced 2026-01-21From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersOpenEvidence's Series D supports a healthcare AI and data analytics platform for doctors, with the financing framed around building medical superintelligence for doctors…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
OpenEvidence · Financing Record
Explore source-linked visual explanations for OpenEvidence. Unsupported claims are withheld while source review continues.
Record 2685 · Recorded date: 2026-01-21
Explore company records →